Crucell corporate brochure (PDF)

68
Crucell’s commitment to the world – Taking responsibility
Crucell was the vaccine industry representative (for the third successive
year) on the formal advisory Program & Policy Committee of the GAVI
Alliance, a public-private partnership with the mission to improve access
to vaccines in the world’s poorest countries. In 2010, the committee
played an important role in the development of a new GAVI Alliance
strategy and business plan for the 2011–2015 period. Other key issues
were how to prioritize new vaccine applications in order to bridge
a funding gap, a strategy for resources mobilization, and health
system strengthening.
Crucell’s innovative work with international organizations dedicated
to immunization program development paved the way for our CEO
Ronald Brus to be nominated by the vaccine industry in industrialized
countries to represent the constituency on the Board of the
GAVI Alliance.
1 Including PERCIVIA events.
www.crucell.com
Crucell also worked on healthcare access improvements as a member of:
y the IFPMA Biologicals & Vaccines Committee, which contributes to
discussions with the World Health Organization (WHO) on general
vaccination policies;
y the advisory group for Project Optimize, a WHO/PATH collaboration
aimed at developing innovative delivery systems to ensure that
vaccines get to the right place, at the right time, in the right condition;
y the European Vaccine Manufacturers (EVM), part of the European
Federation of Pharmaceutical Industries and Associations, which is
committed to working in partnership with EU institutions to support
vaccine policy development and promote vaccine innovation.
Vaccine donations
In 2010, Crucell donated 321,000 doses of MoRu-Viraten® vaccine
against measles and rubella to Unicef to assist earthquake victims
in Haiti. The vaccines were shipped in August 2010. The donation
was made as part of the emergency aid campaign organized by
the International Federation of Pharmaceutical Manufacturers &
Associations (IFPMA), of which Crucell is a member.
Contributing to science
Crucell contributes to the advancement of science and healthcare
by sharing knowledge and expertise. In 2010, Crucell participated in 58 1
international conferences and many more seminars, informal meetings
and media presentations.
Our leading scientists gave over 25 1 public lectures and presentations to
their peers on a wide range of topics, including innovative technologies
for vaccine and antibody discovery, design and manufacturing; novel
approaches to fighting major infectious diseases; and results emerging
from Crucell’s research and development programs.